Expectorant [EPC]

Expectorant [EPC] was reported 206731 times

Drugs of the Expectorant [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 PRESBYACUSIS 140 0.4545
1 BLOOD PRESSURE DIASTOLIC ABNORMAL 1100 0.4321
2 BLOOD PRESSURE SYSTOLIC ABNORMAL 974 0.3937
3 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 178 0.3173
4 NEUROLOGIC NEGLECT SYNDROME 173 0.3112
5 DEEP VEIN THROMBOSIS POSTOPERATIVE 463 0.2312
6 C-REACTIVE PROTEIN 213 0.2298
7 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1455 0.2238
8 X-RAY ABNORMAL 393 0.2196
9 PLEURAL THICKENING 149 0.2178
10 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 447 0.2155
11 MUSCLE INJURY 1764 0.2127
12 LUPUS VULGARIS 265 0.2103
13 CAROTID ARTERY THROMBOSIS 177 0.2085
14 AUTISM SPECTRUM DISORDER 1132 0.2054
15 PLEURAL FIBROSIS 195 0.1914
16 TEMPERATURE REGULATION DISORDER 417 0.1870
17 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1330 0.1854
18 DUODENAL ULCER PERFORATION 1326 0.1781
19 DISLOCATION OF VERTEBRA 402 0.1761
20 FOLLICULITIS 1848 0.1761
21 SWOLLEN JOINT COUNT INCREASED 538 0.1685
22 ADJUSTMENT DISORDER 188 0.1446
23 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 153 0.1441
24 RHEUMATIC FEVER 626 0.1403
25 HELICOBACTER INFECTION 1438 0.1398
26 RHEUMATOID FACTOR POSITIVE 797 0.1378
27 HYPERPARATHYROIDISM SECONDARY 330 0.1316
28 NEPHROGENIC ANAEMIA 607 0.1309
29 FACET JOINT SYNDROME 398 0.1221
30 RETINITIS 210 0.1215
31 HAND DEFORMITY 1578 0.1202
32 C-REACTIVE PROTEIN ABNORMAL 771 0.1201
33 PEMPHIGUS 1449 0.1158
34 BRONCHIAL SECRETION RETENTION 147 0.1154
35 PERIPHERAL VENOUS DISEASE 433 0.1059
36 BLOOD PRESSURE DIASTOLIC DECREASED 762 0.1031
37 IRRITABLE BOWEL SYNDROME 2196 0.1023
38 SYNOVITIS 1844 0.1022
39 BLOOD PRESSURE DIASTOLIC INCREASED 470 0.1017
40 BURSITIS 1224 0.1008
41 BLOOD PRESSURE SYSTOLIC INCREASED 1926 0.0987
42 REBOUND ACID HYPERSECRETION 288 0.0951
43 PERSONALITY DISORDER 243 0.0927
44 PERICARDITIS 1493 0.0888
45 ESSENTIAL HYPERTENSION 158 0.0862
46 FOOD ALLERGY 662 0.0857
47 INFUSION SITE DISCHARGE 149 0.0849
48 BONE EROSION 300 0.0847
49 MATERNAL EXPOSURE TIMING UNSPECIFIED 300 0.0798
50 BLOOD PRESSURE FLUCTUATION 1908 0.0794
51 INFUSION RELATED REACTION 5169 0.0779
52 GLOSSODYNIA 1629 0.0727
53 INFUSION SITE PRURITUS 226 0.0716
54 CONTRAINDICATED PRODUCT ADMINISTERED 2112 0.0697
55 MUSCLE SPASTICITY 855 0.0695
56 LIP DRY 628 0.0691
57 IMPAIRED HEALING 2262 0.0688
58 JOINT RANGE OF MOTION DECREASED 921 0.0686
59 EXPOSURE DURING PREGNANCY 4173 0.0671
60 INFUSION SITE BRUISING 145 0.0671
61 END STAGE RENAL DISEASE 1204 0.0659
62 WOUND 1839 0.0657
63 EAR PAIN 1266 0.0651
64 LOWER RESPIRATORY TRACT INFECTION 2926 0.0643
65 INFUSION SITE HAEMORRHAGE 209 0.0635
66 AUTOIMMUNE DISORDER 602 0.0617
67 INFUSION SITE SWELLING 376 0.0597
68 DEAFNESS NEUROSENSORY 196 0.0595
69 BODY TEMPERATURE INCREASED 1193 0.0584
70 GRIP STRENGTH DECREASED 510 0.0579
71 EXOSTOSIS 527 0.0577
72 RED CELL DISTRIBUTION WIDTH INCREASED 237 0.0570
73 INFUSION SITE ERYTHEMA 476 0.0564
74 WOUND INFECTION 618 0.0564
75 EPIGASTRIC DISCOMFORT 220 0.0563
76 BODY TEMPERATURE DECREASED 550 0.0558
77 SCIATICA 888 0.0556
78 WALKING AID USER 364 0.0552
79 URINE ABNORMALITY 246 0.0541
80 PUSTULAR PSORIASIS 185 0.0538
81 SINUSITIS 5511 0.0537
82 ATELECTASIS 514 0.0531
83 IMMUNODEFICIENCY 793 0.0531
84 INFUSION SITE PAIN 685 0.0531
85 FIBROMYALGIA 1285 0.0528
86 SEASONAL ALLERGY 744 0.0525
87 SINUS CONGESTION 706 0.0522
88 CHRONIC KIDNEY DISEASE 3944 0.0519
89 FOETAL DEATH 263 0.0507
90 PRODUCT SIZE ISSUE 272 0.0506
91 HYPERCHOLESTEROLAEMIA 487 0.0504
92 PRESCRIBED OVERDOSE 950 0.0490
93 HEART RATE DECREASED 1723 0.0490
94 OSTEOARTHRITIS 2070 0.0488
95 NIGHT SWEATS 1572 0.0487
96 ARTHROPATHY 2707 0.0487
97 SCOLIOSIS 300 0.0484
98 SYSTEMIC LUPUS ERYTHEMATOSUS 1712 0.0482
99 EAR PRURITUS 169 0.0481
100 FOREIGN BODY IN THROAT 150 0.0476
101 UPPER-AIRWAY COUGH SYNDROME 391 0.0474
102 BLISTER 2647 0.0471
103 OXYGEN SATURATION DECREASED 2646 0.0470
104 MULTIPLE ALLERGIES 368 0.0469
105 INFUSION SITE REACTION 140 0.0468
106 RASH VESICULAR 225 0.0465
107 THERAPEUTIC PRODUCT EFFECT DECREASED 2081 0.0464
108 STOMATITIS 2811 0.0463
109 SPUTUM DISCOLOURED 439 0.0462
110 ACCIDENTAL OVERDOSE 1687 0.0461
111 POOR VENOUS ACCESS 477 0.0461
112 SINUS DISORDER 912 0.0460
113 JOINT SWELLING 5544 0.0459
114 BREAST CANCER STAGE III 297 0.0458
115 RESPIRATORY TRACT CONGESTION 719 0.0452
116 COELIAC DISEASE 442 0.0450
117 LIVE BIRTH 375 0.0448
118 HEPATIC ENZYME INCREASED 3027 0.0444
119 LOWER LIMB FRACTURE 851 0.0442
120 SPINAL STENOSIS 182 0.0440
121 WEIGHT FLUCTUATION 460 0.0439
122 SPINAL OSTEOARTHRITIS 382 0.0434
123 ARTHRITIS INFECTIVE 197 0.0424
124 INTERVERTEBRAL DISC DEGENERATION 392 0.0423
125 FINGER DEFORMITY 205 0.0423
126 ATTENTION DEFICIT HYPERACTIVITY DISORDER 178 0.0422
127 PULMONARY FIBROSIS 807 0.0420
128 RHEUMATOID ARTHRITIS 4768 0.0420
129 GANGRENE 253 0.0419
130 RED BLOOD CELL SEDIMENTATION RATE INCREASED 463 0.0418
131 UPPER RESPIRATORY TRACT INFECTION 1925 0.0416
132 CHRONIC SINUSITIS 156 0.0415
133 PRODUCTIVE COUGH 1950 0.0408
134 LIVER INJURY 990 0.0403
135 BRONCHIECTASIS 271 0.0402
136 ILL-DEFINED DISORDER 2422 0.0398
137 PERIPHERAL SWELLING 6101 0.0396
138 DYSLIPIDAEMIA 201 0.0395
139 PARANASAL SINUS DISCOMFORT 149 0.0393
140 RESPIRATORY RATE INCREASED 348 0.0392
141 ARTERIAL OCCLUSIVE DISEASE 308 0.0391
142 GAIT INABILITY 1305 0.0390
143 CONTUSION 3759 0.0390
144 OSTEOPENIA 588 0.0387
145 BREAST CANCER STAGE II 319 0.0383
146 FAILURE TO THRIVE 199 0.0383
147 SENSORY LOSS 305 0.0379
148 DISCOMFORT 2310 0.0378
149 GASTROINTESTINAL DISORDER 3377 0.0377
150 RESPIRATORY DISORDER 1125 0.0376
151 HIP ARTHROPLASTY 574 0.0374
152 SWELLING 3504 0.0374
153 INFUSION SITE EXTRAVASATION 233 0.0374
154 OBESITY 596 0.0374
155 JOINT EFFUSION 257 0.0372
156 OBSTRUCTION 148 0.0370
157 NERVE COMPRESSION 341 0.0369
158 INCORRECT PRODUCT ADMINISTRATION DURATION 789 0.0364
159 BREATH SOUNDS ABNORMAL 178 0.0361
160 NASOPHARYNGITIS 6646 0.0360
161 DRUG INTOLERANCE 3474 0.0359
162 BLOOD PRESSURE INCREASED 5464 0.0357
163 HAEMOGLOBIN INCREASED 160 0.0350
164 RHINITIS ALLERGIC 156 0.0350
165 RALES 203 0.0349
166 FOOT DEFORMITY 387 0.0349
167 INCORRECT DRUG ADMINISTRATION RATE 147 0.0345
168 WHEEZING 2031 0.0342
169 MUSCULOSKELETAL PAIN 1786 0.0341
170 EAR INFECTION 907 0.0340
171 PSORIATIC ARTHROPATHY 1381 0.0340
172 MUSCULOSKELETAL CHEST PAIN 524 0.0338
173 SINUS HEADACHE 201 0.0338
174 TYPE 2 DIABETES MELLITUS 1135 0.0337
175 MUSCULOSKELETAL STIFFNESS 2953 0.0337
176 TENDERNESS 351 0.0336
177 LIGAMENT SPRAIN 333 0.0336
178 SKIN ABRASION 158 0.0334
179 BLOOD MAGNESIUM DECREASED 287 0.0332
180 INTENTIONAL PRODUCT USE ISSUE 2910 0.0332
181 BLOOD PRESSURE SYSTOLIC DECREASED 151 0.0332
182 INCORRECT DRUG ADMINISTRATION DURATION 931 0.0331
183 PROTEIN URINE PRESENT 165 0.0331
184 VITAMIN D DEFICIENCY 321 0.0329
185 BACK DISORDER 531 0.0326
186 DYSPNOEA EXERTIONAL 1226 0.0325
187 JOINT DISLOCATION 344 0.0325
188 SYNOVIAL CYST 150 0.0325
189 RIB FRACTURE 668 0.0324
190 RHINORRHOEA 2096 0.0324
191 NASAL CONGESTION 1903 0.0323
192 BODY HEIGHT DECREASED 345 0.0322
193 CONCUSSION 249 0.0321
194 THROAT IRRITATION 1441 0.0321
195 PULMONARY MASS 476 0.0319
196 TOOTH INFECTION 421 0.0319
197 HEART RATE INCREASED 3157 0.0318
198 PRODUCT ADMINISTRATION INTERRUPTED 250 0.0318
199 BRONCHITIS 2352 0.0317
200 FLUID RETENTION 1607 0.0316
201 CYST 392 0.0316
202 TRICUSPID VALVE INCOMPETENCE 250 0.0314
203 INCREASED TENDENCY TO BRUISE 289 0.0314
204 IRON DEFICIENCY 141 0.0313
205 ACUTE RESPIRATORY FAILURE 601 0.0312
206 JOINT STIFFNESS 819 0.0312
207 ULCER HAEMORRHAGE 211 0.0311
208 SARS-COV-2 TEST POSITIVE 411 0.0311
209 CHOKING SENSATION 171 0.0310
210 CYSTITIS 980 0.0307
211 BLOOD CHOLESTEROL INCREASED 1431 0.0307
212 HOSPICE CARE 303 0.0306
213 NECK PAIN 1711 0.0306
214 HIATUS HERNIA 396 0.0306
215 TOOTH ABSCESS 311 0.0305
216 SKIN LACERATION 331 0.0304
217 OSTEOPOROSIS 1252 0.0304
218 VIRAL UPPER RESPIRATORY TRACT INFECTION 144 0.0303
219 APHTHOUS ULCER 234 0.0301
220 DRY THROAT 305 0.0300
221 GASTROOESOPHAGEAL REFLUX DISEASE 2415 0.0300
222 KNEE ARTHROPLASTY 631 0.0299
223 DENTAL CARIES 331 0.0299
224 OROPHARYNGEAL PAIN 2763 0.0298
225 ORAL PAIN 668 0.0298
226 SLEEP APNOEA SYNDROME 569 0.0298
227 HEMIPLEGIA 247 0.0297
228 BACK PAIN 6898 0.0297
229 BLOOD IRON DECREASED 352 0.0296
230 INFECTION 4293 0.0296
231 ARTHRITIS 2332 0.0296
232 MOTOR DYSFUNCTION 301 0.0295
233 CARDIOMEGALY 363 0.0295
234 SLEEP DISORDER 2078 0.0294
235 APPETITE DISORDER 195 0.0294
236 LIVER DISORDER 1304 0.0294
237 ABDOMINAL DISCOMFORT 4928 0.0293
238 TOOTH DISORDER 653 0.0293
239 NEURALGIA 714 0.0293
240 PRE-EXISTING CONDITION IMPROVED 183 0.0293
241 RENAL CYST 232 0.0292
242 NASAL DRYNESS 183 0.0292
243 OEDEMA 1583 0.0292
244 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2061 0.0289
245 SNEEZING 649 0.0289
246 COUGH 8103 0.0289
247 AFFECT LABILITY 277 0.0288
248 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1502 0.0288
249 MUSCLE STRAIN 249 0.0288
250 NEPHROLITHIASIS 1317 0.0287
251 TOOTHACHE 519 0.0286
252 HAEMATOCRIT DECREASED 568 0.0286
253 ORAL CANDIDIASIS 377 0.0286
254 MITRAL VALVE INCOMPETENCE 324 0.0286
255 TASTE DISORDER 578 0.0285
256 DECUBITUS ULCER 232 0.0284
257 FULL BLOOD COUNT ABNORMAL 301 0.0284
258 LUPUS-LIKE SYNDROME 257 0.0283
259 HYPERVOLAEMIA 140 0.0283
260 MUSCULOSKELETAL DISCOMFORT 485 0.0282
261 FLANK PAIN 264 0.0281
262 EMPHYSEMA 283 0.0280
263 LIMB INJURY 762 0.0280
264 PAIN IN JAW 792 0.0279
265 ROTATOR CUFF SYNDROME 358 0.0278
266 HYPERLIPIDAEMIA 333 0.0278
267 MOBILITY DECREASED 1996 0.0278
268 SECRETION DISCHARGE 347 0.0277
269 FEELING OF BODY TEMPERATURE CHANGE 162 0.0276
270 RETCHING 589 0.0276
271 INCREASED UPPER AIRWAY SECRETION 141 0.0274
272 MYOSITIS 246 0.0274
273 SKIN ATROPHY 157 0.0273
274 POOR QUALITY SLEEP 587 0.0272
275 PSYCHOLOGICAL TRAUMA 235 0.0272
276 SPINAL COMPRESSION FRACTURE 225 0.0272
277 DRY MOUTH 2208 0.0272
278 RED BLOOD CELL COUNT DECREASED 778 0.0272
279 HEART RATE IRREGULAR 614 0.0271
280 ARTHRALGIA 11283 0.0271
281 BACK INJURY 295 0.0271
282 CONFUSIONAL STATE 4379 0.0271
283 EAR DISCOMFORT 278 0.0271
284 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1301 0.0271
285 DIVERTICULUM 192 0.0270
286 LUNG DISORDER 1322 0.0269
287 CARDIAC MURMUR 233 0.0269
288 EATING DISORDER 573 0.0269
289 HYPERSENSITIVITY 4992 0.0269
290 POLYP 176 0.0269
291 HYPERKERATOSIS 148 0.0268
292 CHILLS 3118 0.0266
293 RESPIRATORY TRACT INFECTION 692 0.0265
294 HAEMORRHOIDS 518 0.0265
295 VITAMIN D DECREASED 227 0.0265
296 DERMATITIS CONTACT 301 0.0264
297 PRODUCT USE COMPLAINT 415 0.0263
298 MIGRAINE 2510 0.0263
299 RENAL INJURY 779 0.0262
300 CHEST DISCOMFORT 2683 0.0262
301 MASS 366 0.0262
302 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 178 0.0262
303 ASTHMA 2959 0.0262
304 BLOOD URINE PRESENT 496 0.0261
305 THERAPY NON-RESPONDER 1173 0.0261
306 GASTROENTERITIS VIRAL 471 0.0261
307 HEAD DISCOMFORT 461 0.0260
308 NEPHROPATHY 243 0.0260
309 WEIGHT INCREASED 5822 0.0260
310 ECCHYMOSIS 178 0.0259
311 DYSPEPSIA 2554 0.0259
312 DECREASED INTEREST 153 0.0259
313 COORDINATION ABNORMAL 361 0.0259
314 LYMPHOCYTE COUNT DECREASED 456 0.0258
315 PULMONARY CONGESTION 340 0.0258
316 SKIN WARM 150 0.0258
317 SMALL INTESTINAL OBSTRUCTION 317 0.0257
318 BLOOD POTASSIUM DECREASED 773 0.0257
319 LOCALISED INFECTION 616 0.0254
320 ROAD TRAFFIC ACCIDENT 1065 0.0254
321 URINE ODOUR ABNORMAL 149 0.0253
322 HAND FRACTURE 179 0.0252
323 ABDOMINAL PAIN UPPER 5199 0.0252
324 HEADACHE 15777 0.0251
325 LOWER GASTROINTESTINAL HAEMORRHAGE 186 0.0251
326 DIVERTICULITIS 696 0.0251
327 INFLAMMATION 1293 0.0250
328 FEELING DRUNK 186 0.0250
329 BRAIN FOG 392 0.0250
330 HYPERTENSION 5291 0.0250
331 SKIN HAEMORRHAGE 370 0.0249
332 PYREXIA 8634 0.0249
333 CONSTIPATION 5428 0.0249
334 FREQUENT BOWEL MOVEMENTS 672 0.0249
335 SEDATION 651 0.0248
336 NODULE 324 0.0248
337 HEPATIC CIRRHOSIS 465 0.0247
338 LYMPHOEDEMA 171 0.0247
339 EXPIRED PRODUCT ADMINISTERED 821 0.0247
340 GENERAL SYMPTOM 185 0.0247
341 URINARY TRACT INFECTION 4208 0.0246
342 UTERINE LEIOMYOMA 180 0.0246
343 FACIAL PAIN 219 0.0245
344 GOUT 440 0.0245
345 FATIGUE 19092 0.0245
346 GINGIVAL PAIN 195 0.0245
347 TOOTH FRACTURE 270 0.0245
348 PHARYNGITIS STREPTOCOCCAL 265 0.0245
349 EYE INFECTION 276 0.0244
350 HAEMOPTYSIS 679 0.0243
351 PAIN IN EXTREMITY 7152 0.0242
352 OBSTRUCTIVE AIRWAYS DISORDER 270 0.0242
353 MENISCUS INJURY 149 0.0242
354 INSOMNIA 6454 0.0242
355 FULL BLOOD COUNT DECREASED 488 0.0242
356 PAIN 14865 0.0242
357 HYPOXIA 852 0.0242
358 THERAPEUTIC RESPONSE UNEXPECTED 1085 0.0242
359 NEUTROPHIL COUNT INCREASED 247 0.0241
360 RENAL PAIN 255 0.0240
361 SPINAL PAIN 281 0.0240
362 ONYCHOCLASIS 165 0.0240
363 INTERVERTEBRAL DISC PROTRUSION 524 0.0239
364 PNEUMONIA 7741 0.0239
365 FEELING HOT 1462 0.0238
366 IMPAIRED GASTRIC EMPTYING 325 0.0238
367 CHEST PAIN 4410 0.0238
368 HYPERHIDROSIS 3067 0.0238
369 RENAL TUBULAR NECROSIS 233 0.0237
370 HYPOAESTHESIA 3552 0.0237
371 CATARACT 1410 0.0237
372 PREGNANCY 474 0.0236
373 MIDDLE INSOMNIA 442 0.0236
374 NAIL DISORDER 207 0.0236
375 KIDNEY INFECTION 464 0.0236
376 JOINT INJURY 505 0.0236
377 PELVIC FRACTURE 184 0.0236
378 BLOOD COUNT ABNORMAL 358 0.0236
379 INFLUENZA 2629 0.0236
380 FEELING COLD 656 0.0235
381 MICTURITION URGENCY 269 0.0235
382 FEELING JITTERY 448 0.0235
383 PHARYNGEAL SWELLING 230 0.0235
384 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 402 0.0234
385 SKIN INFECTION 263 0.0234
386 DYSURIA 862 0.0234
387 CLOSTRIDIUM DIFFICILE INFECTION 511 0.0234
388 IRON DEFICIENCY ANAEMIA 216 0.0234
389 RENAL FAILURE 3103 0.0233
390 APHONIA 326 0.0233
391 URTICARIA 3911 0.0233
392 MALNUTRITION 261 0.0233
393 EPISTAXIS 1742 0.0233
394 ASTHENIA 8749 0.0232
395 WEIGHT DECREASED 6491 0.0232
396 ARTHROPOD BITE 172 0.0232
397 CARPAL TUNNEL SYNDROME 325 0.0232
398 BLEPHAROSPASM 146 0.0232
399 PRESCRIBED UNDERDOSE 462 0.0231
400 NIGHTMARE 799 0.0231
401 HYPOAESTHESIA ORAL 348 0.0231
402 BLOOD PRESSURE ABNORMAL 459 0.0231
403 RESTLESS LEGS SYNDROME 419 0.0230
404 OROPHARYNGEAL DISCOMFORT 208 0.0230
405 BLOOD POTASSIUM INCREASED 373 0.0229
406 COVID-19 4029 0.0229
407 RHINITIS 185 0.0229
408 DYSPNOEA 12974 0.0229
409 DYSSTASIA 669 0.0229
410 DECREASED ACTIVITY 247 0.0229
411 LUNG INFILTRATION 202 0.0228
412 POST-TRAUMATIC STRESS DISORDER 153 0.0228
413 PHOTOPHOBIA 429 0.0228
414 ECONOMIC PROBLEM 345 0.0227
415 FOOT FRACTURE 431 0.0227
416 LIMB DISCOMFORT 701 0.0226
417 SKIN LESION 621 0.0226
418 TROPONIN INCREASED 172 0.0226
419 IMPAIRED QUALITY OF LIFE 325 0.0226
420 VIRAL INFECTION 751 0.0225
421 HEPATIC STEATOSIS 420 0.0225
422 CELLULITIS 1130 0.0224
423 DELIRIUM 778 0.0224
424 WRIST FRACTURE 268 0.0223
425 PARAESTHESIA ORAL 322 0.0223
426 HEMIPARESIS 378 0.0223
427 MUSCULAR WEAKNESS 2531 0.0222
428 THROAT TIGHTNESS 602 0.0222
429 DIZZINESS POSTURAL 215 0.0221
430 CHOKING 432 0.0221
431 FAECES DISCOLOURED 480 0.0221
432 GAIT DISTURBANCE 4237 0.0221
433 INCONTINENCE 234 0.0221
434 PULMONARY HYPERTENSION 461 0.0221
435 PNEUMONIA BACTERIAL 203 0.0221
436 LARGE INTESTINE POLYP 152 0.0219
437 DIARRHOEA 14163 0.0219
438 ATRIAL FLUTTER 175 0.0219
439 ACUTE KIDNEY INJURY 3350 0.0219
440 RASH ERYTHEMATOUS 1046 0.0219
441 INJURY 1537 0.0218
442 ANKYLOSING SPONDYLITIS 288 0.0218
443 ANAL INCONTINENCE 196 0.0218
444 DYSPHONIA 1272 0.0217
445 PULMONARY THROMBOSIS 237 0.0217
446 TUBULOINTERSTITIAL NEPHRITIS 407 0.0217
447 BLOOD SODIUM DECREASED 409 0.0217
448 ABSCESS 346 0.0217
449 GALLBLADDER DISORDER 386 0.0216
450 DECREASED APPETITE 5020 0.0216
451 ATRIAL SEPTAL DEFECT 181 0.0216
452 FAECES SOFT 157 0.0216
453 ORAL DISORDER 158 0.0215
454 PHARYNGITIS 267 0.0215
455 HERPES ZOSTER 1236 0.0215
456 RESPIRATORY SYNCYTIAL VIRUS INFECTION 187 0.0215
457 EUPHORIC MOOD 219 0.0214
458 PRODUCT USE ISSUE 4014 0.0213
459 BONE DISORDER 389 0.0213
460 POST PROCEDURAL INFECTION 173 0.0213
461 BONE PAIN 1246 0.0212
462 DISABILITY 420 0.0212
463 GROIN PAIN 186 0.0212
464 SPLENOMEGALY 248 0.0211
465 BOWEL MOVEMENT IRREGULARITY 162 0.0211
466 RECTAL HAEMORRHAGE 908 0.0211
467 ILLNESS 2176 0.0211
468 HYPERSOMNIA 605 0.0211
469 DIZZINESS 10510 0.0211
470 BLOOD ALBUMIN DECREASED 167 0.0210
471 EOSINOPHIL COUNT INCREASED 175 0.0210
472 MUSCLE SPASMS 3843 0.0209
473 RENAL FAILURE CHRONIC 161 0.0209
474 AGEUSIA 522 0.0209
475 BLOOD TEST ABNORMAL 294 0.0209
476 POSTOPERATIVE WOUND INFECTION 141 0.0209
477 TENDONITIS 323 0.0208
478 URINARY INCONTINENCE 618 0.0208
479 FALL 6939 0.0208
480 TREATMENT FAILURE 1727 0.0208
481 DRY EYE 1036 0.0207
482 SPINAL DISORDER 196 0.0207
483 NASAL DISCOMFORT 164 0.0207
484 MATERNAL EXPOSURE BEFORE PREGNANCY 141 0.0206
485 HOT FLUSH 1552 0.0206
486 WHITE BLOOD CELL COUNT INCREASED 789 0.0205
487 PALPITATIONS 2406 0.0205
488 PERIPHERAL COLDNESS 282 0.0205
489 DEHYDRATION 2737 0.0205
490 IMMUNOSUPPRESSION 181 0.0205
491 PRODUCT USE IN UNAPPROVED INDICATION 5074 0.0205
492 OEDEMA PERIPHERAL 2495 0.0204
493 OSTEOMYELITIS 370 0.0204
494 HAEMATOCHEZIA 1125 0.0204
495 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 346 0.0204
496 SUPRAVENTRICULAR TACHYCARDIA 195 0.0203
497 INFLUENZA LIKE ILLNESS 1675 0.0203
498 ANXIETY 5779 0.0203
499 FRUSTRATION TOLERANCE DECREASED 164 0.0203
500 SCRATCH 214 0.0203
501 DEFAECATION URGENCY 142 0.0202
502 NAUSEA 15984 0.0202
503 BLOOD CALCIUM DECREASED 227 0.0202
504 BALANCE DISORDER 1744 0.0202
505 DYSPHAGIA 1912 0.0201
506 NEUROPATHY PERIPHERAL 1916 0.0201
507 PRURITUS 7729 0.0201
508 ATRIAL FIBRILLATION 1958 0.0201
509 FISTULA 226 0.0201
510 PLEURAL EFFUSION 1222 0.0201
511 HAEMOGLOBIN DECREASED 2062 0.0201
512 HEAD INJURY 635 0.0200
513 MENTAL STATUS CHANGES 557 0.0200
514 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 587 0.0200
515 HYPOKINESIA 290 0.0200
516 ORAL HERPES 389 0.0199
517 COVID-19 PNEUMONIA 235 0.0199
518 SOMNOLENCE 4005 0.0199
519 MUSCLE ATROPHY 252 0.0199
520 RASH 8663 0.0199
521 AMNESIA 1289 0.0198
522 LYMPHADENOPATHY 701 0.0198
523 ALOPECIA 3884 0.0198
524 OCULAR DISCOMFORT 222 0.0198
525 GINGIVAL BLEEDING 270 0.0198
526 NOCTURIA 240 0.0198
527 POLLAKIURIA 824 0.0197
528 MUSCLE TIGHTNESS 320 0.0197
529 GASTROINTESTINAL PAIN 217 0.0197
530 CANDIDA INFECTION 333 0.0197
531 FLUSHING 2003 0.0197
532 INITIAL INSOMNIA 202 0.0197
533 VOMITING 9233 0.0196
534 INSURANCE ISSUE 300 0.0196
535 BACTERIAL INFECTION 366 0.0196
536 AORTIC ANEURYSM 149 0.0196
537 BLADDER DISORDER 194 0.0195
538 HIP FRACTURE 628 0.0195
539 CLOSTRIDIUM DIFFICILE COLITIS 207 0.0195
540 ABDOMINAL PAIN 4532 0.0195
541 LACERATION 183 0.0194
542 HALLUCINATION 1466 0.0194
543 LABORATORY TEST ABNORMAL 573 0.0194
544 HERNIA 375 0.0194
545 GASTRIC DISORDER 657 0.0191
546 BLOOD PRESSURE DECREASED 1272 0.0191
547 GLAUCOMA 368 0.0191
548 FLATULENCE 1083 0.0191
549 TEMPERATURE INTOLERANCE 197 0.0191
550 INTERNAL HAEMORRHAGE 218 0.0191
551 FOETAL EXPOSURE DURING PREGNANCY 1550 0.0190
552 HAIR COLOUR CHANGES 237 0.0190
553 FUNGAL INFECTION 634 0.0190
554 MAJOR DEPRESSION 139 0.0190
555 CHOLELITHIASIS 622 0.0189
556 ARTERIOSCLEROSIS 178 0.0189
557 GASTRITIS 497 0.0189
558 APHASIA 570 0.0189
559 DYSARTHRIA 709 0.0188
560 DEFORMITY 176 0.0188
561 SKIN ULCER 486 0.0188
562 LIVER FUNCTION TEST INCREASED 403 0.0188
563 SPINAL FRACTURE 376 0.0187
564 FEELING ABNORMAL 4482 0.0187
565 HYDRONEPHROSIS 140 0.0187
566 PARAESTHESIA 2940 0.0187
567 FURUNCLE 148 0.0187
568 MOVEMENT DISORDER 598 0.0186
569 COLITIS 705 0.0186
570 HYPOPHAGIA 474 0.0185
571 UROSEPSIS 171 0.0185
572 URINE OUTPUT DECREASED 162 0.0185
573 ORAL DISCOMFORT 257 0.0185
574 PLATELET COUNT INCREASED 241 0.0185
575 BLOOD UREA INCREASED 309 0.0184
576 PRESYNCOPE 448 0.0184
577 PNEUMOTHORAX 292 0.0184
578 SCAB 210 0.0184
579 BEDRIDDEN 242 0.0184
580 THERAPEUTIC RESPONSE SHORTENED 610 0.0184
581 GLOMERULAR FILTRATION RATE DECREASED 226 0.0184
582 ANGINA PECTORIS 525 0.0183
583 PERICARDIAL EFFUSION 423 0.0183
584 DISEASE RECURRENCE 866 0.0182
585 ULCER 289 0.0181
586 THYROID DISORDER 280 0.0181
587 LETHARGY 1044 0.0181
588 MYALGIA 3082 0.0181
589 MATERNAL EXPOSURE DURING PREGNANCY 1615 0.0181
590 FEEDING DISORDER 367 0.0181
591 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3260 0.0181
592 MEMORY IMPAIRMENT 2484 0.0181
593 GASTROINTESTINAL INFECTION 162 0.0181
594 NERVOUSNESS 944 0.0180
595 ABNORMAL FAECES 148 0.0180
596 WHITE BLOOD CELL COUNT DECREASED 1953 0.0180
597 LEUKOCYTOSIS 325 0.0179
598 EYE PAIN 1013 0.0179
599 C-REACTIVE PROTEIN INCREASED 653 0.0179
600 BRONCHOSPASM 255 0.0179
601 POST PROCEDURAL COMPLICATION 343 0.0178
602 THIRST 319 0.0178
603 NERVE INJURY 198 0.0178
604 SKIN DISCOLOURATION 818 0.0178
605 GENERALISED OEDEMA 220 0.0178
606 DYSGEUSIA 1320 0.0177
607 MACULAR DEGENERATION 212 0.0177
608 PSEUDOMONAS INFECTION 152 0.0177
609 ABDOMINAL DISTENSION 1849 0.0177
610 DEPRESSION 4020 0.0177
611 COAGULOPATHY 294 0.0176
612 STAPHYLOCOCCAL INFECTION 581 0.0176
613 ACUTE HEPATIC FAILURE 240 0.0175
614 SKIN DISORDER 584 0.0175
615 MUSCULOSKELETAL DISORDER 333 0.0175
616 HAIR DISORDER 144 0.0175
617 UPPER GASTROINTESTINAL HAEMORRHAGE 294 0.0175
618 SINUS TACHYCARDIA 248 0.0174
619 VASCULITIS 203 0.0174
620 SCAR 298 0.0174
621 PULMONARY OEDEMA 778 0.0174
622 HEREDITARY ANGIOEDEMA 186 0.0173
623 ANKLE FRACTURE 268 0.0173
624 UPPER LIMB FRACTURE 344 0.0172
625 ASPIRATION 189 0.0172
626 LUNG INFECTION 268 0.0172
627 TREMOR 2857 0.0172
628 CONDITION AGGRAVATED 5232 0.0172
629 DRUG INEFFECTIVE 22642 0.0172
630 BREAST PAIN 183 0.0171
631 SLUGGISHNESS 175 0.0171
632 IMMUNE SYSTEM DISORDER 226 0.0171
633 EYE DISCHARGE 178 0.0171
634 CARDIAC FAILURE CONGESTIVE 1376 0.0171
635 HAIR TEXTURE ABNORMAL 229 0.0171
636 BASAL CELL CARCINOMA 267 0.0171
637 COLD SWEAT 301 0.0171
638 TINNITUS 781 0.0170
639 TRANSFUSION 178 0.0170
640 LACRIMATION INCREASED 512 0.0169
641 OESOPHAGITIS 185 0.0169
642 MALAISE 7423 0.0169
643 TACHYCARDIA 1495 0.0168
644 PLATELET COUNT DECREASED 1792 0.0168
645 CHROMATURIA 379 0.0168
646 HYPOTENSION 3362 0.0167
647 VENTRICULAR EXTRASYSTOLES 174 0.0167
648 GASTRIC ULCER 318 0.0167
649 SENSATION OF FOREIGN BODY 141 0.0167
650 INTENTIONAL DOSE OMISSION 476 0.0167
651 GASTROENTERITIS 243 0.0166
652 RASH PRURITIC 900 0.0166
653 BLOOD CREATININE INCREASED 1082 0.0166
654 BURNING SENSATION 1159 0.0165
655 DECREASED IMMUNE RESPONSIVENESS 161 0.0164
656 GASTROINTESTINAL HAEMORRHAGE 1371 0.0164
657 PRODUCT DISTRIBUTION ISSUE 152 0.0164
658 SEPSIS 1827 0.0164
659 RENAL DISORDER 763 0.0164
660 PROCEDURAL PAIN 454 0.0163
661 DEEP VEIN THROMBOSIS 1059 0.0163
662 HEPATIC FAILURE 488 0.0162
663 INTESTINAL OBSTRUCTION 610 0.0162
664 EYE SWELLING 602 0.0162
665 HALLUCINATION, VISUAL 341 0.0161
666 SPEECH DISORDER 846 0.0161
667 PRODUCT DOSE OMISSION IN ERROR 457 0.0161
668 THINKING ABNORMAL 299 0.0160
669 PALLOR 436 0.0160
670 SPINAL OPERATION 197 0.0160
671 GENERAL PHYSICAL HEALTH DETERIORATION 1848 0.0160
672 PANIC ATTACK 582 0.0160
673 CORONARY ARTERY DISEASE 483 0.0159
674 PNEUMONIA ASPIRATION 398 0.0159
675 TOOTH EXTRACTION 198 0.0159
676 PHOTOSENSITIVITY REACTION 262 0.0158
677 OVARIAN CYST 158 0.0158
678 OFF LABEL USE 13809 0.0158
679 MOUTH ULCERATION 332 0.0157
680 MUSCLE TWITCHING 363 0.0157
681 BLOOD ALKALINE PHOSPHATASE INCREASED 391 0.0157
682 INTENTIONAL PRODUCT MISUSE 1378 0.0157
683 VERTIGO 959 0.0157
684 PRODUCT ADMINISTRATION ERROR 316 0.0156
685 TRANSIENT ISCHAEMIC ATTACK 526 0.0156
686 ELECTROLYTE IMBALANCE 181 0.0156
687 DIPLOPIA 404 0.0155
688 BACTERAEMIA 184 0.0155
689 ANHEDONIA 407 0.0155
690 RASH MACULAR 541 0.0155
691 FLUID OVERLOAD 225 0.0154
692 CHOLECYSTITIS 184 0.0154
693 ANAEMIA 2943 0.0154
694 VISION BLURRED 2116 0.0154
695 HYPOKALAEMIA 711 0.0154
696 SKIN FISSURES 301 0.0154
697 IMPAIRED WORK ABILITY 326 0.0152
698 THROMBOSIS 1220 0.0151
699 EYE DISORDER 498 0.0151
700 PSYCHOMOTOR HYPERACTIVITY 251 0.0151
701 UVEITIS 205 0.0151
702 UNRESPONSIVE TO STIMULI 389 0.0151
703 TENDON RUPTURE 186 0.0150
704 CONJUNCTIVITIS 279 0.0150
705 MADAROSIS 174 0.0150
706 INJECTION SITE EXTRAVASATION 184 0.0149
707 RESPIRATORY FAILURE 1086 0.0149
708 ADVERSE EVENT 1371 0.0149
709 LIP SWELLING 495 0.0148
710 VITREOUS FLOATERS 146 0.0148
711 SWELLING FACE 967 0.0148
712 ADRENAL INSUFFICIENCY 180 0.0148
713 ERYTHEMA 3048 0.0148
714 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 810 0.0147
715 HEPATOMEGALY 145 0.0147
716 HYPOMAGNESAEMIA 205 0.0147
717 LOSS OF CONSCIOUSNESS 1884 0.0147
718 BRAIN OEDEMA 184 0.0146
719 CRYING 529 0.0145
720 COLITIS ULCERATIVE 649 0.0145
721 ABDOMINAL PAIN LOWER 367 0.0145
722 OVERDOSE 3126 0.0145
723 INTERNATIONAL NORMALISED RATIO INCREASED 413 0.0145
724 PARANOIA 249 0.0144
725 SUBDURAL HAEMATOMA 206 0.0144
726 SYNCOPE 1436 0.0143
727 SWOLLEN TONGUE 448 0.0143
728 MYDRIASIS 184 0.0143
729 RESTLESSNESS 524 0.0143
730 RESPIRATORY DISTRESS 395 0.0143
731 DRUG EFFECT LESS THAN EXPECTED 212 0.0143
732 ADVERSE DRUG REACTION 1284 0.0143
733 CORONARY ARTERY OCCLUSION 196 0.0143
734 HAEMATURIA 489 0.0143
735 PETECHIAE 148 0.0142
736 CHOLECYSTECTOMY 162 0.0142
737 SKIN CANCER 305 0.0142
738 HYPOTHYROIDISM 452 0.0141
739 DEMENTIA 395 0.0141
740 LOCAL SWELLING 246 0.0141
741 ANOSMIA 203 0.0140
742 QUALITY OF LIFE DECREASED 188 0.0140
743 PULMONARY EMBOLISM 1329 0.0140
744 PNEUMONITIS 380 0.0139
745 DRUG LEVEL DECREASED 141 0.0138
746 TACHYPNOEA 188 0.0138
747 VISUAL IMPAIRMENT 1711 0.0138
748 DISORIENTATION 547 0.0138
749 BRAIN INJURY 138 0.0137
750 NEUTROPHIL COUNT DECREASED 560 0.0137
751 URINARY RETENTION 456 0.0137
752 HYPOACUSIS 586 0.0136
753 INCREASED APPETITE 260 0.0136
754 DELUSION 211 0.0136
755 ACCIDENT 161 0.0135
756 METASTASES TO BONE 221 0.0135
757 CARDIOMYOPATHY 198 0.0134
758 IMPAIRED DRIVING ABILITY 152 0.0134
759 PSORIASIS 1740 0.0133
760 DIABETES MELLITUS 1012 0.0133
761 ERUCTATION 256 0.0132
762 ALANINE AMINOTRANSFERASE INCREASED 812 0.0132
763 PHARYNGEAL OEDEMA 203 0.0132
764 DEAFNESS 345 0.0132
765 PRURITUS GENERALISED 285 0.0132
766 PLASMA CELL MYELOMA 514 0.0132
767 UNEVALUABLE EVENT 995 0.0131
768 PRODUCT TASTE ABNORMAL 178 0.0131
769 PULMONARY ARTERIAL HYPERTENSION 189 0.0130
770 LIVER FUNCTION TEST ABNORMAL 379 0.0130
771 SENSORY DISTURBANCE 209 0.0130
772 ANAPHYLACTIC REACTION 719 0.0130
773 INTESTINAL PERFORATION 146 0.0130
774 DEVICE RELATED INFECTION 200 0.0130
775 FEBRILE NEUTROPENIA 860 0.0130
776 HYPERCALCAEMIA 160 0.0129
777 EYE PRURITUS 434 0.0129
778 BIPOLAR DISORDER 140 0.0129
779 NEOPLASM 147 0.0128
780 ASPARTATE AMINOTRANSFERASE INCREASED 672 0.0126
781 HUNGER 175 0.0126
782 CARDIAC DISORDER 1175 0.0125
783 PRODUCT DOSE OMISSION ISSUE 3693 0.0125
784 ENCEPHALOPATHY 307 0.0125
785 DISTURBANCE IN ATTENTION 672 0.0124
786 BLOOD BILIRUBIN INCREASED 336 0.0124
787 COGNITIVE DISORDER 575 0.0123
788 HAEMATOMA 319 0.0123
789 HAEMATEMESIS 312 0.0123
790 ORTHOSTATIC HYPOTENSION 214 0.0123
791 SKIN EXFOLIATION 1034 0.0122
792 INCORRECT DOSE ADMINISTERED 2794 0.0122
793 METASTASES TO LUNG 141 0.0122
794 THROMBOCYTOPENIA 1362 0.0122
795 ILEUS 151 0.0121
796 PANCREATITIS 642 0.0121
797 ASCITES 357 0.0121
798 ATAXIA 144 0.0121
799 ACTIVITIES OF DAILY LIVING IMPAIRED 239 0.0121
800 DEPRESSED MOOD 638 0.0121
801 MENTAL IMPAIRMENT 292 0.0120
802 MALIGNANT MELANOMA 161 0.0120
803 FRACTURE 227 0.0120
804 EYE HAEMORRHAGE 160 0.0120
805 HAEMORRHAGE 1248 0.0119
806 MEDICATION ERROR 663 0.0119
807 PROSTATIC SPECIFIC ANTIGEN INCREASED 164 0.0119
808 CYANOSIS 187 0.0119
809 THERAPY PARTIAL RESPONDER 184 0.0118
810 BLOOD TRIGLYCERIDES INCREASED 208 0.0118
811 DRUG EFFECT INCOMPLETE 426 0.0117
812 IRRITABILITY 705 0.0117
813 OCULAR HYPERAEMIA 555 0.0117
814 DYSKINESIA 472 0.0116
815 HYPONATRAEMIA 653 0.0116
816 FEMUR FRACTURE 359 0.0116
817 THERAPY CESSATION 595 0.0116
818 RENAL IMPAIRMENT 969 0.0115
819 TOOTH LOSS 239 0.0115
820 SURGERY 675 0.0115
821 MULTIPLE SCLEROSIS 548 0.0114
822 DRY SKIN 1528 0.0114
823 BLINDNESS UNILATERAL 161 0.0114
824 UNDERDOSE 830 0.0114
825 DERMATITIS 238 0.0113
826 CENTRAL NERVOUS SYSTEM LESION 156 0.0113
827 MENTAL DISORDER 493 0.0113
828 DEVICE OCCLUSION 159 0.0113
829 HEPATITIS 289 0.0113
830 ABASIA 279 0.0113
831 ADVERSE REACTION 149 0.0112
832 AGITATION 825 0.0112
833 CEREBROVASCULAR ACCIDENT 1901 0.0112
834 DISEASE PROGRESSION 1326 0.0112
835 RASH PAPULAR 250 0.0111
836 SEIZURE 1282 0.0111
837 METASTASES TO LIVER 195 0.0111
838 SEROTONIN SYNDROME 213 0.0111
839 EJECTION FRACTION DECREASED 172 0.0111
840 INTERSTITIAL LUNG DISEASE 535 0.0110
841 DIABETES MELLITUS INADEQUATE CONTROL 195 0.0110
842 SKIN REACTION 155 0.0110
843 PRODUCT DOSE OMISSION 715 0.0109
844 ABNORMAL DREAMS 302 0.0109
845 MULTIPLE SCLEROSIS RELAPSE 747 0.0109
846 ACUTE MYOCARDIAL INFARCTION 321 0.0109
847 BLOOD LACTATE DEHYDROGENASE INCREASED 172 0.0108
848 VENTRICULAR TACHYCARDIA 177 0.0107
849 PROTEINURIA 203 0.0107
850 TREATMENT NONCOMPLIANCE 581 0.0106
851 DRUG-INDUCED LIVER INJURY 333 0.0106
852 COMPLICATION ASSOCIATED WITH DEVICE 154 0.0106
853 EMOTIONAL DISORDER 325 0.0105
854 MOOD SWINGS 336 0.0105
855 INTENTIONAL OVERDOSE 673 0.0105
856 PARALYSIS 150 0.0105
857 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 745 0.0105
858 BONE DENSITY DECREASED 328 0.0105
859 BRADYCARDIA 554 0.0104
860 EYE IRRITATION 599 0.0104
861 THERAPEUTIC RESPONSE DECREASED 630 0.0104
862 DRUG TOXICITY 141 0.0103
863 ANGER 350 0.0103
864 THERAPY INTERRUPTED 737 0.0103
865 SEPTIC SHOCK 446 0.0102
866 DRUG ADMINISTRATION ERROR 312 0.0102
867 MULTIPLE FRACTURES 167 0.0102
868 MOOD ALTERED 277 0.0101
869 EXTRA DOSE ADMINISTERED 408 0.0101
870 HYPERGLYCAEMIA 366 0.0100
871 RASH GENERALISED 260 0.0100
872 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 234 0.0100
873 ARRHYTHMIA 474 0.0100
874 NEOPLASM PROGRESSION 348 0.0100
875 BONE LOSS 150 0.0100
876 DRUG ABUSE 829 0.0099
877 RENAL FAILURE ACUTE 421 0.0099
878 PRODUCT PHYSICAL ISSUE 200 0.0099
879 PANCYTOPENIA 553 0.0099
880 OSTEONECROSIS OF JAW 243 0.0098
881 MYELODYSPLASTIC SYNDROME 142 0.0098
882 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1981 0.0098
883 FEAR 262 0.0097
884 PAIN OF SKIN 262 0.0097
885 HOSPITALISATION 1492 0.0097
886 COLON CANCER 144 0.0097
887 ABNORMAL BEHAVIOUR 382 0.0096
888 EOSINOPHILIA 168 0.0096
889 RESPIRATORY ARREST 263 0.0095
890 PRODUCT AVAILABILITY ISSUE 217 0.0095
891 MALIGNANT NEOPLASM PROGRESSION 967 0.0094
892 MYOCARDIAL INFARCTION 1643 0.0094
893 PELVIC PAIN 170 0.0093
894 JAUNDICE 251 0.0093
895 PRODUCT PRESCRIBING ERROR 222 0.0093
896 EMOTIONAL DISTRESS 1127 0.0093
897 CEREBRAL HAEMORRHAGE 327 0.0091
898 SUICIDE ATTEMPT 553 0.0091
899 INJECTION SITE BRUISING 727 0.0091
900 HYPERKALAEMIA 319 0.0091
901 LYMPHOMA 140 0.0090
902 ANAPHYLACTIC SHOCK 233 0.0090
903 LEUKOPENIA 446 0.0089
904 LUNG NEOPLASM MALIGNANT 359 0.0087
905 CARDIAC ARREST 721 0.0087
906 HALLUCINATION, AUDITORY 137 0.0086
907 SUICIDAL IDEATION 789 0.0086
908 CYTOKINE RELEASE SYNDROME 172 0.0086
909 TRANSAMINASES INCREASED 190 0.0085
910 BLOOD GLUCOSE INCREASED 1601 0.0085
911 BLOOD GLUCOSE DECREASED 408 0.0085
912 ECZEMA 444 0.0085
913 SHOCK 195 0.0085
914 ACNE 638 0.0084
915 METABOLIC ACIDOSIS 268 0.0084
916 NO ADVERSE EVENT 1513 0.0083
917 STEVENS-JOHNSON SYNDROME 185 0.0083
918 AGGRESSION 415 0.0083
919 MENORRHAGIA 162 0.0082
920 VAGINAL HAEMORRHAGE 356 0.0082
921 NEUTROPENIA 1109 0.0081
922 BLINDNESS 327 0.0080
923 DEATH 6897 0.0080
924 DRUG EFFECT DECREASED 431 0.0080
925 INJECTION SITE RASH 245 0.0080
926 INJECTION SITE PRURITUS 534 0.0080
927 PRODUCT QUALITY ISSUE 1082 0.0080
928 GLYCOSYLATED HAEMOGLOBIN INCREASED 200 0.0079
929 BLOOD GLUCOSE ABNORMAL 146 0.0079
930 ACUTE RESPIRATORY DISTRESS SYNDROME 139 0.0079
931 HYPOGLYCAEMIA 381 0.0078
932 PRODUCT COMPLAINT 199 0.0078
933 INJECTION SITE REACTION 538 0.0078
934 INJECTION SITE MASS 289 0.0078
935 PREMATURE BABY 234 0.0078
936 PRODUCT PRESCRIBING ISSUE 169 0.0077
937 NERVOUS SYSTEM DISORDER 238 0.0076
938 CARDIAC FAILURE 611 0.0076
939 DEPRESSED LEVEL OF CONSCIOUSNESS 301 0.0076
940 CARDIO-RESPIRATORY ARREST 315 0.0075
941 PSYCHOTIC DISORDER 220 0.0074
942 MELAENA 163 0.0074
943 NEEDLE ISSUE 215 0.0074
944 INJECTION SITE URTICARIA 181 0.0074
945 MUCOSAL INFLAMMATION 192 0.0073
946 HEPATOTOXICITY 163 0.0073
947 DRUG DOSE OMISSION 1209 0.0073
948 INJECTION SITE ERYTHEMA 902 0.0073
949 PRODUCT SUBSTITUTION ISSUE 416 0.0072
950 INJECTION SITE SWELLING 551 0.0072
951 VISUAL ACUITY REDUCED 238 0.0072
952 CONVULSION 408 0.0071
953 NEOPLASM MALIGNANT 466 0.0070
954 SKIN IRRITATION 319 0.0070
955 WITHDRAWAL SYNDROME 291 0.0069
956 INJECTION SITE PAIN 2097 0.0068
957 BLOOD CREATINE PHOSPHOKINASE INCREASED 195 0.0068
958 DEVICE ISSUE 605 0.0067
959 DRUG INTERACTION 1035 0.0065
960 COMA 309 0.0065
961 INJECTION SITE HAEMORRHAGE 509 0.0064
962 RASH MACULO-PAPULAR 139 0.0062
963 ERECTILE DYSFUNCTION 158 0.0061
964 WRONG TECHNIQUE IN DRUG USAGE PROCESS 212 0.0058
965 DERMATITIS ATOPIC 299 0.0057
966 SKIN BURNING SENSATION 406 0.0057
967 EXPOSURE VIA SKIN CONTACT 146 0.0056
968 TOXICITY TO VARIOUS AGENTS 949 0.0056
969 EPILEPSY 172 0.0056
970 ABORTION SPONTANEOUS 223 0.0056
971 DEVICE DISLOCATION 237 0.0054
972 DEVICE MALFUNCTION 368 0.0052
973 ELECTROCARDIOGRAM QT PROLONGED 188 0.0052
974 HEPATIC FUNCTION ABNORMAL 195 0.0052
975 ANGIOEDEMA 226 0.0051
976 MULTIPLE ORGAN DYSFUNCTION SYNDROME 138 0.0049
977 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 157 0.0046
978 BREAST CANCER 431 0.0046
979 OSTEONECROSIS 151 0.0046
980 COMPLETED SUICIDE 374 0.0045
981 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 206 0.0044
982 DRUG EXPOSURE DURING PREGNANCY 149 0.0044
983 DEVICE LEAKAGE 189 0.0044
984 DRUG DEPENDENCE 691 0.0043
985 PRODUCT ADHESION ISSUE 149 0.0042
986 ACCIDENTAL EXPOSURE TO PRODUCT 425 0.0041
987 DRUG WITHDRAWAL SYNDROME 323 0.0037
988 RHABDOMYOLYSIS 153 0.0037
989 DEVICE DIFFICULT TO USE 198 0.0030
990 PRODUCT STORAGE ERROR 257 0.0029
991 PROSTATE CANCER 190 0.0024
992 DRUG DOSE OMISSION BY DEVICE 139 0.0018